Clinical Trials Directory

Trials / Completed

CompletedNCT00288405

The ENTERPRISE Study - Study of the Enterprise Self-Expanding Stent System

Cordis Neurovascular Feasibility Study of the Enterprise Self-Expanding Stent System to Facilitate Endovascular Coil Embolization of Wide- Neck Saccular Intracranial Artery Aneurysms

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
31 (actual)
Sponsor
Codman & Shurtleff · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To evaluate the safety and feasibility of the Cordis Neurovascular Self-Expanding Stent System to facilitate endovascular coil embolization of wide neck saccular intracranial aneurysms. Cordis Self Expanding Stent for use with embolic coils for the treatment of wide-neck, intracranial, saccular aneurysms arising from a parent vessel

Detailed description

This is a multi-center, prospective, non-randomized feasibility study including 30 subjects. Subjects will receive a safety follow-up evaluation at 30 days (+ two weeks) and an efficacy follow-up evaluation at 6 months (+ four weeks).

Conditions

Interventions

TypeNameDescription
DEVICECordis Self Expanding Stent

Timeline

Start date
2004-06-01
Completion
2005-12-01
First posted
2006-02-08
Last updated
2012-05-02

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT00288405. Inclusion in this directory is not an endorsement.